AAAAAA

   
Results: 1-24 |
Results: 24
PLASMA TGF-BETA IN STAGE-III NSCLC PATIENTS PRIOR TO AND DURING RADIOTHERAPY WITH OR WITHOUT CARBOPLATIN
Authors: FOKKEMA E VUJASKOVIC Z VANDERLEEST AHD GROEN HJM
Citation: E. Fokkema et al., PLASMA TGF-BETA IN STAGE-III NSCLC PATIENTS PRIOR TO AND DURING RADIOTHERAPY WITH OR WITHOUT CARBOPLATIN, European journal of cancer, 34, 1998, pp. 129-129
EFFECTS OF GEMCITABINE ON RENAL-FUNCTION IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
Authors: GIETEMA JA GROEN HJM MEIJER S SMIT EF
Citation: Ja. Gietema et al., EFFECTS OF GEMCITABINE ON RENAL-FUNCTION IN PATIENTS WITH NONSMALL CELL LUNG-CANCER, European journal of cancer, 34(1), 1998, pp. 199-202
BRAIN-ONLY METASTASES OF SMALL-CELL LUNG-CANCER - EFFICACY OF WHOLE-BRAIN RADIOTHERAPY - AN EORTC PHASE-II STUDY
Authors: POSTMUS PE HAAXMAREICHE H GREGOR A GROEN HJM LEWINSKI T SCOLARD T KIRKPATRICK A CURRAN D SAHMOUD T GIACCONE G
Citation: Pe. Postmus et al., BRAIN-ONLY METASTASES OF SMALL-CELL LUNG-CANCER - EFFICACY OF WHOLE-BRAIN RADIOTHERAPY - AN EORTC PHASE-II STUDY, Radiotherapy and oncology, 46(1), 1998, pp. 29-32
FEASIBILITY OF TUMOR IMAGING USING L-3-[IODINE-123]-IODO-ALPHA-METHYL-TYROSINE IN EXTRACRANIAL TUMORS
Authors: JAGER PL FRANSSEN EJF KOOL W SZABO BG HOEKSTRA HJ GROEN HJM DEVRIES EGE VANIMHOFF GW VAALBURG W PIERS DA
Citation: Pl. Jager et al., FEASIBILITY OF TUMOR IMAGING USING L-3-[IODINE-123]-IODO-ALPHA-METHYL-TYROSINE IN EXTRACRANIAL TUMORS, The Journal of nuclear medicine, 39(10), 1998, pp. 1736-1743
A PHASE-II STUDY OF PACLITAXEL IN HEAVILY PRETREATED PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: SMIT EF FOKKEMA E BIESMA B GROEN HJM SNOEK W POSTMUS PE
Citation: Ef. Smit et al., A PHASE-II STUDY OF PACLITAXEL IN HEAVILY PRETREATED PATIENTS WITH SMALL-CELL LUNG-CANCER, British Journal of Cancer, 77(2), 1998, pp. 347-351
BROAD PHASE-II AND PHARMACOKINETIC STUDY OF METHOXY-MORPHOLINO DOXORUBICIN (FCE 23762-MMRDX) IN NON-SMALL-CELL LUNG-CANCER, RENAL-CANCER AND OTHER SOLID TUMOR PATIENTS
Authors: BAKKER M DROZ JP HANAUSKE AR VERWEIJ J VANOOSTEROM AT GROEN HJM PACCIARINI MA DOMENIGONI L VANWEISSENBRUCH F PIANEZZOLA E DEVRIES EGE
Citation: M. Bakker et al., BROAD PHASE-II AND PHARMACOKINETIC STUDY OF METHOXY-MORPHOLINO DOXORUBICIN (FCE 23762-MMRDX) IN NON-SMALL-CELL LUNG-CANCER, RENAL-CANCER AND OTHER SOLID TUMOR PATIENTS, British Journal of Cancer, 77(1), 1998, pp. 139-146
ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP
Authors: VANZANDWIJK N GROEN HJM POSTMUS PE BURGHOUTS JTW TENVELDE GPM ARDIZZONI A SMITH IE BAAS P SAHMOUD T KIRKPATRICK A DALESIO O GIACCONE G
Citation: N. Vanzandwijk et al., ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, European journal of cancer, 33(11), 1997, pp. 1759-1766
APPROACHES TO LUNG-CANCER TREATMENT USING THE CD3E-X-GP-2-DIRECTED BISPECIFIC MONOCLONAL-ANTIBODY BIS-1
Authors: KROESEN BJ NIEKEN J SLEIJFER DT MOLEMA G DEVRIES EGE GROEN HJM HELFRICH W THE TH MULDER NH DELEIJ L
Citation: Bj. Kroesen et al., APPROACHES TO LUNG-CANCER TREATMENT USING THE CD3E-X-GP-2-DIRECTED BISPECIFIC MONOCLONAL-ANTIBODY BIS-1, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 203-206
MECHANISMS FOR HIGH METHOXYMORPHOLINO DOXORUBICIN CYTOTOXICITY IN DOXORUBICIN-RESISTANT TUMOR-CELL LINES
Authors: BAKKER M RENES J GROENHUIJZEN A VISSER P TIMMERBOSSCHA H MULLER M GROEN HJM SMIT EF DEVRIES EGE
Citation: M. Bakker et al., MECHANISMS FOR HIGH METHOXYMORPHOLINO DOXORUBICIN CYTOTOXICITY IN DOXORUBICIN-RESISTANT TUMOR-CELL LINES, International journal of cancer, 73(3), 1997, pp. 362-366
A PHASE-II STUDY OF GEMCITABINE IN THE TR EATMENT OF NON-SMALL-CELL LUNG-CANCER
Authors: LECHEVALIER T GOTTFRIED M GATZEMEIER U SHEPHERD F WEYNANTS P COTTIER B GROEN HJM ROSSO R MATTSON K CORTESFUNES H TONATO M BURKES RL VOI M PONZIO A
Citation: T. Lechevalier et al., A PHASE-II STUDY OF GEMCITABINE IN THE TR EATMENT OF NON-SMALL-CELL LUNG-CANCER, Bulletin du cancer, 84(3), 1997, pp. 282-288
RANDOMIZED COMPARISON OF ETOPOSIDE PHARMACOKINETICS AFTER ORAL ETOPOSIDE PHOSPHATE AND ORAL ETOPOSIDE
Authors: DEJONG RS MULDER NH UGES DRA KAUL S WINOGRAD B SLEIJFER DT GROEN HJM WILLEMSE PHB VANDERGRAAF WTA DEVRIES EGE
Citation: Rs. Dejong et al., RANDOMIZED COMPARISON OF ETOPOSIDE PHARMACOKINETICS AFTER ORAL ETOPOSIDE PHOSPHATE AND ORAL ETOPOSIDE, British Journal of Cancer, 75(11), 1997, pp. 1660-1666
STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL
Authors: POSTMUS PE SCAGLIOTTI G GROEN HJM GOZZELINO F BURGHOUTS JTW CURRAN D SAHMOUD T KIRKPATRICK A GIACCONE G SPLINTER TAW
Citation: Pe. Postmus et al., STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL, European journal of cancer, 32A(9), 1996, pp. 1498-1503
ACTIVITY OF GEMCITABINE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER -A MULTICENTER, EXTENDED PHASE-II STUDY
Authors: GATZEMEIER U SHEPHERD FA LECHEVALIER T WEYNANTS P COTTIER B GROEN HJM ROSSO R MATTSON K CORTESFUNES H TONATO M BURKES RL GOTTFRIED M VOI M
Citation: U. Gatzemeier et al., ACTIVITY OF GEMCITABINE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER -A MULTICENTER, EXTENDED PHASE-II STUDY, European journal of cancer, 32A(2), 1996, pp. 243-248
DETERMINATION OF FUNCTIONAL P-GLYCOPROTEIN IN PATIENTS WITH SOLID TUMORS BY TECHNETIUM-99M-SESTAMIBI SCINTIGRAPHY WITH AND WITHOUT PSC-833
Authors: FRANSSEN EJF KOOL W BAKKER M VANDERGRAAF WTA HOLLEMA H GROEN HJM MULLER E SMIT EF DEVRIES EGE PIERS DA
Citation: Ejf. Franssen et al., DETERMINATION OF FUNCTIONAL P-GLYCOPROTEIN IN PATIENTS WITH SOLID TUMORS BY TECHNETIUM-99M-SESTAMIBI SCINTIGRAPHY WITH AND WITHOUT PSC-833, The Journal of nuclear medicine, 37(5), 1996, pp. 257-257
PULMONARY-FUNCTION CHANGES IN LUNG-CANCER PATIENTS TREATED WITH RADIATION WITH OR WITHOUT CARBOPLATIN
Authors: GROEN HJM VANDERMARK TW VANDERLEEST AHD DEVRIES EGE MULDER NH
Citation: Hjm. Groen et al., PULMONARY-FUNCTION CHANGES IN LUNG-CANCER PATIENTS TREATED WITH RADIATION WITH OR WITHOUT CARBOPLATIN, American journal of respiratory and critical care medicine, 152(6), 1995, pp. 2044-2048
TOXICITY AND EFFICACY OF ESCALATING DOSAGES OF RECOMBINANT HUMAN INTERLEUKIN-6 AFTER CHEMOTHERAPY IN PATIENTS WITH BREAST-CANCER OR NON-SMALL-CELL LUNG-CANCER
Authors: VELDHUIS GJ WILLEMSE PHB SLEIJFER DT VANDERGRAAF WTA GROEN HJM LIMBURG PC MULDER NH DEVRIES EGE
Citation: Gj. Veldhuis et al., TOXICITY AND EFFICACY OF ESCALATING DOSAGES OF RECOMBINANT HUMAN INTERLEUKIN-6 AFTER CHEMOTHERAPY IN PATIENTS WITH BREAST-CANCER OR NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2585-2593
PHARMACOKINETICS AND SCINTIGRAPHY OF INDIUM-111-DTPA-MOC-31 IN SMALL-CELL LUNG-CARCINOMA
Authors: KOSTERINK JGW DEJONGE MWA SMIT EF PIERS DA KENGEN RAM POSTMUS PE SHOCHAT D GROEN HJM THE HT DELEIJ L
Citation: Jgw. Kosterink et al., PHARMACOKINETICS AND SCINTIGRAPHY OF INDIUM-111-DTPA-MOC-31 IN SMALL-CELL LUNG-CARCINOMA, The Journal of nuclear medicine, 36(12), 1995, pp. 2356-2362
CARBOPLATIN-INDUCED AND CISPLATIN-INDUCED POTENTIATION OF MODERATE-DOSE RADIATION CYTOTOXICITY IN HUMAN LUNG-CANCER CELL-LINES
Authors: GROEN HJM SLEIJFER S MEIJER C KAMPINGA HH KONINGS AWT DEVRIES EGE MULDER NH
Citation: Hjm. Groen et al., CARBOPLATIN-INDUCED AND CISPLATIN-INDUCED POTENTIATION OF MODERATE-DOSE RADIATION CYTOTOXICITY IN HUMAN LUNG-CANCER CELL-LINES, British Journal of Cancer, 72(6), 1995, pp. 1406-1411
PHASE-I STUDY OF HIGH-DOSE EPIRUBICIN AND VINORELBINE IN PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER STAGE IIIB-IV
Authors: BAKKER M GROEN HJM SMIT EF SMEETS J RIGGI M POSTMUS PE
Citation: M. Bakker et al., PHASE-I STUDY OF HIGH-DOSE EPIRUBICIN AND VINORELBINE IN PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER STAGE IIIB-IV, British Journal of Cancer, 72(6), 1995, pp. 1547-1550
CONTINUOUS CARBOPLATIN INFUSION DURING 6 WEEKS RADIOTHERAPY IN LOCALLY INOPERABLE NON-SMALL-CELL LUNG-CANCER - A PHASE-I AND PHARMACOKINETIC STUDY
Authors: GROEN HJM VANDERLEEST AHD DEVRIES EGE UGES DRA SZABO BG MULDER NH
Citation: Hjm. Groen et al., CONTINUOUS CARBOPLATIN INFUSION DURING 6 WEEKS RADIOTHERAPY IN LOCALLY INOPERABLE NON-SMALL-CELL LUNG-CANCER - A PHASE-I AND PHARMACOKINETIC STUDY, British Journal of Cancer, 72(4), 1995, pp. 992-997
SURGICAL RESECTION FOR SMALL-CELL CARCINOMA OF THE LUNG - A RETROSPECTIVE STUDY
Authors: SMIT EF GROEN HJM TIMENS W DEBOER WJ POSTMUS PE
Citation: Ef. Smit et al., SURGICAL RESECTION FOR SMALL-CELL CARCINOMA OF THE LUNG - A RETROSPECTIVE STUDY, Thorax, 49(1), 1994, pp. 20-22
EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-6 IN CANCER-PATIENTS - A PHASE I-II STUDY
Authors: VANGAMEREN MM WILLEMSE PHB MULDER NH LIMBURG PC GROEN HJM VELLENGA E DEVRIES EGE
Citation: Mm. Vangameren et al., EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-6 IN CANCER-PATIENTS - A PHASE I-II STUDY, Blood, 84(5), 1994, pp. 1434-1441
CARBOPLATIN AS 2ND LINE TREATMENT FOR RECURRENT OR PROGRESSIVE BRAIN METASTASES FROM SMALL-CELL LUNG-CANCER
Authors: GROEN HJM SMIT EF HAAXMAREICHE H POSTMUS PE
Citation: Hjm. Groen et al., CARBOPLATIN AS 2ND LINE TREATMENT FOR RECURRENT OR PROGRESSIVE BRAIN METASTASES FROM SMALL-CELL LUNG-CANCER, European journal of cancer, 29A(12), 1993, pp. 1696-1699
DIFFUSION CAPACITY IN HEART-TRANSPLANT RECIPIENTS
Authors: GROEN HJM BOGAARD JM BALK AHMM KHO SG HOP WCJ HILVERING C
Citation: Hjm. Groen et al., DIFFUSION CAPACITY IN HEART-TRANSPLANT RECIPIENTS, Chest, 104(6), 1993, pp. 1938-1939
Risultati: 1-24 |